PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35462930-7	2022	The other patient acquired EGFR T790M and MET amplification post-dacomitinib and acquired CCDC6-RET fusion after osimertinib treatment.	osimertinib	113-124	coiled-coil domain containing 6	Homo sapiens	90-95	
33641722-0	2021	Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.	osimertinib	57-68	coiled-coil domain containing 6	Homo sapiens	24-29